Reldesemtiv Slows Decline in Muscle Control Needed for Speech, Phase 2 Trial Analysis
 

Reldesemtiv May Reduce Functional Decline in Fast Progressing ALS, New Analysis Suggests

In Fast Advancing ALS, Reldesemtiv May Lower Functional Decline, Data Says


Reldesemtiv Slows Decline in Muscle Control Needed for Speech, Phase 2 Trial Analysis Finds
Reldesemtiv in ALS Patients Slows Decline in Speech Muscle Control, Trial Data Show

FORTITUDE-ALS study results suggest reldesemtiv may have efficaciousness in amyotrophic lateral sclerosis